West Highland White Terrier Pulmonary Fibrosis

Colleague,

Your suspicion is very high on my list for an 11-year-old Westie with these clinical signs and radiographic findings. Idiopathic pulmonary fibrosis is a notorious and tragic disease in this breed. My approach is to confirm the diagnosis by exclusion and then manage for quality of life, as this is a progressive, non-curable condition.

Here's how I would structure the workup and management plan.

1. Diagnostic Confirmation (Diagnosis of Exclusion):
Before committing to an IPF diagnosis, we must rule out other causes of interstitial lung disease and respiratory distress.
* Infectious Disease: A bronchoalveolar lavage (BAL) for cytology and culture (aerobic, anaerobic, Mycoplasma) is the gold standard to rule out infectious or inflammatory causes like chronic bronchitis or eosinophilic bronchopneumopathy. Given the age and likely stability issues, this step requires careful risk-assessment.
* Cardiac Disease: The crackles and tachypnea could have a cardiac component. Left-sided congestive heart failure must be ruled out. More importantly, IPF leads to secondary pulmonary hypertension (PH), which is a major driver of the clinical signs.
* Neoplasia: Lymphangitic carcinomatosis can mimic IPF radiographically.

My recommended next steps would be:
* Echocardiogram: This is non-negotiable. It will rule out primary left-sided heart disease and, critically, confirm and quantify the severity of pulmonary hypertension (via tricuspid regurgitation jet velocity). This is essential before starting sildenafil. Dr. Obi, I'll need your expertise here to assess for PH and rule out concurrent primary cardiac pathology.
* Thoracic CT: This is far more sensitive than radiographs for characterizing the interstitial pattern (ground-glass opacities, traction bronchiectasis) and ruling out occult neoplasia. Dr. Lin, could you comment on the utility of CT versus radiographs in these cases?

2. Therapeutic Plan:
Once we have a presumptive diagnosis (often made without the highly invasive lung biopsy), management is multi-modal and palliative.
* Sildenafil: This is the cornerstone for managing secondary PH. I typically start at 1-2 mg/kg PO TID. The goal is to reduce pulmonary arterial pressure, improve perfusion, and alleviate the workload on the right heart.
* Prednisone/Prednisolone: The fibrotic component is poorly responsive to steroids. However, an anti-inflammatory dose (0.5 mg/kg/day) can be beneficial for any concurrent inflammatory component. I use it, but I counsel owners that it's not a magic bullet and wean to the lowest effective dose.
* Bronchodilators (Theophylline): Many of these terriers have concurrent bronchomalacia. A trial with theophylline can be helpful for the cough and any dynamic airway collapse component.
* Cough Suppressants: As the disease progresses, a dry, hacking cough can become a major quality of life issue. Hydrocodone or butorphanol can provide significant relief.

3. Quality of Life Management:
This is paramount. Instructing the owner to monitor the sleeping/resting respiratory rate (RRR) at home is one of the most valuable tools we have. An RRR consistently >35-40 breaths/min indicates progression. We also focus on environmental management—avoiding heat, stress, and smoke—and modifying exercise to tolerance.

This is a tough diagnosis with a median survival time often quoted around 12-18 months. My role is to confirm the diagnosis as best we can, manage the secondary effects like PH, and give the owner tools to maximize comfort and quality of life for as long as possible.

High confidence in this general approach, but the echo is the critical next step.

Dr. Elena Vasquez, DVM, DACVIM (SAIM)

Thank you for the consult. The signalment and history are certainly classic for idiopathic pulmonary fibrosis (IPF). Before anchoring on that diagnosis, let's refine the radiographic interpretation, as "diffuse interstitial pattern" can be a challenging finding.

First, a technical review of the films is critical. Ensure they are well-inflated inspiratory views and adequately exposed. Expiratory artifact is a common mimic of interstitial disease and can lead to over-interpretation.

Assuming good technique, we should characterize the pattern more precisely. In classic IPF, we typically see a diffuse, unstructured interstitial pattern, often with a caudodorsal distribution that becomes more generalized over time. A prominent bronchial pattern is also a very common concurrent finding in these terriers.

Most importantly, I would pay close attention to the cardiovascular structures. Pulmonary hypertension is a critical and common sequela of IPF. Look for radiographic signs such as an enlarged main pulmonary artery segment on the DV/VD view, right ventricular enlargement (a reverse-D shape), and enlarged pulmonary arteries relative to the veins.

While survey radiographs are suggestive, they are not specific for IPF. High-resolution computed tomography (HRCT) is the current non-invasive gold standard for confirming and characterizing the extent of fibrosis. HRCT can reveal ground-glass opacities, traction bronchiectasis, and honeycombing that are pathognomonic. Definitive diagnosis requires lung biopsy, but this is often not pursued due to patient morbidity.

My primary differentials based on radiographs alone would include:

Idiopathic Pulmonary Fibrosis (IPF): Top of the list given signalment.

Atypical pneumonia or chronic inflammatory lung disease.

Neoplastic infiltration (e.g., lymphangitic carcinomatosis).

Cardiogenic edema, though the distribution and chronicity may be atypical.

From an imaging perspective, the next steps are a rigorous review of the existing films and strong consideration for HRCT to confirm and stage the disease. An echocardiogram is essential to evaluate for secondary pulmonary hypertension. I will defer to Dr. Obi for the cardiac assessment and to Dr. Vasquez for the specifics of medical management.

Colleagues, this is a classic and challenging presentation in this breed. While idiopathic pulmonary fibrosis is the leading differential, we must address the significant overlap in clinical signs with congestive heart failure. My primary concern is ruling out or staging concurrent cardiac disease before initiating therapies like prednisone, which could be catastrophic in a patient with occult heart failure due to fluid retention.

The key points from a cardiology perspective are:

Cardiac Comorbidity is Common: An 11-year-old Westie is at prime age for degenerative mitral valve disease (DMVD). The inspiratory crackles and tachypnea are hallmark signs of left-sided CHF, and the interstitial pattern on radiographs can be indistinguishable from chronic, low-grade cardiogenic edema. We cannot safely assume this is purely respiratory.

Pulmonary Hypertension (PH) Classification: The potential use of sildenafil makes defining the cause of PH critical. If this is pre-capillary PH secondary to chronic hypoxia from IPF (WHO Group 3), sildenafil is appropriate. However, if this is post-capillary PH secondary to left atrial hypertension from DMVD (WHO Group 2), the primary treatment is managing the left-sided failure with diuretics, pimobendan, and an ACE inhibitor. Using sildenafil alone in that case would be inappropriate.

Essential Diagnostics: Before proceeding, a full cardiac workup is non-negotiable.

* Auscultation: Is a murmur present? A grade III/VI or louder left apical systolic murmur would significantly increase my suspicion for hemodynamically important DMVD.
* Echocardiogram: This is the most important next step. I would assess for left atrial size (LA:Ao ratio), LV function, severity of mitral regurgitation, and estimate pulmonary artery pressures via the tricuspid regurgitation velocity. This will definitively stage any underlying heart disease and classify the type of PH present.
* NT-proBNP: A useful adjunctive test. A normal result would lower my suspicion for CHF, while a high result would confirm cardiac stretch is contributing to the signs.

In summary, we must exclude a cardiac contribution before labeling this as IPF and starting treatment. An echocardiogram will provide the necessary information to proceed safely. I'll defer to Dr. Vasquez on the specifics of IPF management and Dr. Lin for a detailed radiographic interpretation.